nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—kidney cancer—vascular cancer	0.9	1	CtDrD
Pazopanib—STK10—renal vein—vascular cancer	0.0155	0.436	CbGeAlD
Pazopanib—FLT4—blood vessel—vascular cancer	0.00216	0.0605	CbGeAlD
Pazopanib—FGF1—blood vessel—vascular cancer	0.00191	0.0537	CbGeAlD
Pazopanib—FLT1—blood vessel—vascular cancer	0.00168	0.047	CbGeAlD
Pazopanib—KDR—blood vessel—vascular cancer	0.00142	0.0397	CbGeAlD
Pazopanib—SH2B3—cardiac atrium—vascular cancer	0.00133	0.0374	CbGeAlD
Pazopanib—KIT—blood vessel—vascular cancer	0.00126	0.0352	CbGeAlD
Pazopanib—PDGFRB—blood vessel—vascular cancer	0.00123	0.0344	CbGeAlD
Pazopanib—RIOK2—cardiac atrium—vascular cancer	0.00112	0.0313	CbGeAlD
Pazopanib—PI4KB—cardiac atrium—vascular cancer	0.000988	0.0277	CbGeAlD
Pazopanib—PIP4K2C—cardiac atrium—vascular cancer	0.000867	0.0243	CbGeAlD
Pazopanib—FGFR1—cardiac atrium—vascular cancer	0.00086	0.0241	CbGeAlD
Pazopanib—FGF1—cardiac atrium—vascular cancer	0.000774	0.0217	CbGeAlD
Pazopanib—FLT1—cardiac atrium—vascular cancer	0.000678	0.019	CbGeAlD
Pazopanib—EPHB6—cardiac atrium—vascular cancer	0.00067	0.0188	CbGeAlD
Pazopanib—TAOK3—cardiac atrium—vascular cancer	0.000639	0.0179	CbGeAlD
Pazopanib—KDR—cardiac atrium—vascular cancer	0.000573	0.0161	CbGeAlD
Pazopanib—MAP2K5—cardiac atrium—vascular cancer	0.000573	0.0161	CbGeAlD
Pazopanib—CSF1R—cardiac atrium—vascular cancer	0.000559	0.0157	CbGeAlD
Pazopanib—PDGFRB—cardiac atrium—vascular cancer	0.000496	0.0139	CbGeAlD
Pazopanib—ABCB1—blood vessel—vascular cancer	0.00034	0.00953	CbGeAlD
Pazopanib—FGF1—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.000206	0.00321	CbGpPWpGaD
Pazopanib—FGF1—Signaling by ERBB4—TSC2—vascular cancer	0.000203	0.00316	CbGpPWpGaD
Pazopanib—ITK—Immune System—CD34—vascular cancer	0.000201	0.00314	CbGpPWpGaD
Pazopanib—FGFR3—B Cell Activation—TSC2—vascular cancer	0.0002	0.00312	CbGpPWpGaD
Pazopanib—PDGFRB—PI-3K cascade—TSC2—vascular cancer	0.0002	0.00311	CbGpPWpGaD
Pazopanib—PDGFRB—PI3K/AKT activation—TSC2—vascular cancer	0.000195	0.00304	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by Insulin receptor—TSC2—vascular cancer	0.000194	0.00303	CbGpPWpGaD
Pazopanib—FGF1—Downstream signal transduction—TSC2—vascular cancer	0.000194	0.00302	CbGpPWpGaD
Pazopanib—PDGFRB—GAB1 signalosome—TSC2—vascular cancer	0.000193	0.00301	CbGpPWpGaD
Pazopanib—FGF1—Signaling by FGFR—TSC2—vascular cancer	0.000193	0.003	CbGpPWpGaD
Pazopanib—FGF1—Signaling by ERBB2—TSC2—vascular cancer	0.000192	0.00299	CbGpPWpGaD
Pazopanib—FGFR3—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.000191	0.00298	CbGpPWpGaD
Pazopanib—FGF1—DAP12 signaling—TSC2—vascular cancer	0.000191	0.00297	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—WWTR1—vascular cancer	0.000189	0.00296	CbGpPWpGaD
Pazopanib—PDGFRB—Role of LAT2/NTAL/LAB on calcium mobilization—TSC2—vascular cancer	0.000189	0.00295	CbGpPWpGaD
Pazopanib—FGF1—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	0.000188	0.00293	CbGpPWpGaD
Pazopanib—FGFR3—Adaptive Immune System—CD34—vascular cancer	0.000186	0.0029	CbGpPWpGaD
Pazopanib—LYN—Role of LAT2/NTAL/LAB on calcium mobilization—TSC2—vascular cancer	0.000185	0.00288	CbGpPWpGaD
Pazopanib—FGF1—DAP12 interactions—TSC2—vascular cancer	0.000179	0.0028	CbGpPWpGaD
Pazopanib—FGF1—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.000179	0.0028	CbGpPWpGaD
Pazopanib—FGF1—Signaling by FGFR in disease—TSC2—vascular cancer	0.000179	0.0028	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by SCF-KIT—TSC2—vascular cancer	0.000178	0.00278	CbGpPWpGaD
Pazopanib—FGF1—Signaling by EGFR—TSC2—vascular cancer	0.000178	0.00277	CbGpPWpGaD
Pazopanib—LCK—Constitutive PI3K/AKT Signaling in Cancer—TSC2—vascular cancer	0.000178	0.00277	CbGpPWpGaD
Pazopanib—FGF1—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.000176	0.00275	CbGpPWpGaD
Pazopanib—FGF1—Signaling by PDGF—TSC2—vascular cancer	0.000175	0.00274	CbGpPWpGaD
Pazopanib—KIT—Signaling by SCF-KIT—TSC2—vascular cancer	0.000175	0.00273	CbGpPWpGaD
Pazopanib—MAP2K5—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.000171	0.00267	CbGpPWpGaD
Pazopanib—FGFR2—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.00017	0.00266	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism—HBA1—vascular cancer	0.00017	0.00265	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by ERBB4—TSC2—vascular cancer	0.000168	0.00262	CbGpPWpGaD
Pazopanib—KIT—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.000167	0.00261	CbGpPWpGaD
Pazopanib—FGF1—B Cell Activation—TSC2—vascular cancer	0.000166	0.00259	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by SCF-KIT—TSC2—vascular cancer	0.000166	0.00259	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by SCF-KIT—TSC2—vascular cancer	0.000166	0.00258	CbGpPWpGaD
Pazopanib—KIT—Signaling by ERBB4—TSC2—vascular cancer	0.000165	0.00257	CbGpPWpGaD
Pazopanib—FGFR2—Downstream signal transduction—TSC2—vascular cancer	0.00016	0.0025	CbGpPWpGaD
Pazopanib—LCK—PI-3K cascade—TSC2—vascular cancer	0.00016	0.0025	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by FGFR—TSC2—vascular cancer	0.000159	0.00249	CbGpPWpGaD
Pazopanib—FGF1—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.000159	0.00248	CbGpPWpGaD
Pazopanib—FGFR1—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.000159	0.00248	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by ERBB2—TSC2—vascular cancer	0.000159	0.00247	CbGpPWpGaD
Pazopanib—PDGFRA—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.000158	0.00247	CbGpPWpGaD
Pazopanib—FGFR2—DAP12 signaling—TSC2—vascular cancer	0.000158	0.00246	CbGpPWpGaD
Pazopanib—KIT—Downstream signal transduction—TSC2—vascular cancer	0.000157	0.00245	CbGpPWpGaD
Pazopanib—KIT—Signaling by FGFR—TSC2—vascular cancer	0.000157	0.00244	CbGpPWpGaD
Pazopanib—LCK—PI3K/AKT activation—TSC2—vascular cancer	0.000156	0.00244	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by ERBB4—TSC2—vascular cancer	0.000156	0.00244	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by ERBB4—TSC2—vascular cancer	0.000156	0.00243	CbGpPWpGaD
Pazopanib—KIT—Signaling by ERBB2—TSC2—vascular cancer	0.000156	0.00243	CbGpPWpGaD
Pazopanib—FGFR2—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	0.000156	0.00243	CbGpPWpGaD
Pazopanib—LCK—GAB1 signalosome—TSC2—vascular cancer	0.000155	0.00242	CbGpPWpGaD
Pazopanib—KIT—DAP12 signaling—TSC2—vascular cancer	0.000155	0.00242	CbGpPWpGaD
Pazopanib—FGF1—Adaptive Immune System—CD34—vascular cancer	0.000155	0.00241	CbGpPWpGaD
Pazopanib—FGFR3—Disease—WWTR1—vascular cancer	0.000154	0.0024	CbGpPWpGaD
Pazopanib—KIT—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	0.000153	0.00238	CbGpPWpGaD
Pazopanib—LCK—Role of LAT2/NTAL/LAB on calcium mobilization—TSC2—vascular cancer	0.000152	0.00236	CbGpPWpGaD
Pazopanib—ITK—Innate Immune System—TSC2—vascular cancer	0.00015	0.00233	CbGpPWpGaD
Pazopanib—FGFR1—Downstream signal transduction—TSC2—vascular cancer	0.000149	0.00233	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by SCF-KIT—TSC2—vascular cancer	0.000149	0.00233	CbGpPWpGaD
Pazopanib—PDGFRA—Downstream signal transduction—TSC2—vascular cancer	0.000149	0.00232	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by FGFR—TSC2—vascular cancer	0.000149	0.00232	CbGpPWpGaD
Pazopanib—FGFR2—DAP12 interactions—TSC2—vascular cancer	0.000148	0.00232	CbGpPWpGaD
Pazopanib—FGFR2—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.000148	0.00232	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by FGFR in disease—TSC2—vascular cancer	0.000148	0.00232	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by FGFR—TSC2—vascular cancer	0.000148	0.00231	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by ERBB2—TSC2—vascular cancer	0.000148	0.00231	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by ERBB2—TSC2—vascular cancer	0.000147	0.0023	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by EGFR—TSC2—vascular cancer	0.000147	0.0023	CbGpPWpGaD
Pazopanib—FGFR1—DAP12 signaling—TSC2—vascular cancer	0.000147	0.00229	CbGpPWpGaD
Pazopanib—FGFR3—Signaling by NGF—TSC2—vascular cancer	0.000147	0.00229	CbGpPWpGaD
Pazopanib—PDGFRA—DAP12 signaling—TSC2—vascular cancer	0.000147	0.00229	CbGpPWpGaD
Pazopanib—LYN—Signaling by SCF-KIT—TSC2—vascular cancer	0.000146	0.00228	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.000146	0.00227	CbGpPWpGaD
Pazopanib—KIT—Signaling by FGFR in disease—TSC2—vascular cancer	0.000146	0.00227	CbGpPWpGaD
Pazopanib—KIT—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.000146	0.00227	CbGpPWpGaD
Pazopanib—KIT—DAP12 interactions—TSC2—vascular cancer	0.000146	0.00227	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by PDGF—TSC2—vascular cancer	0.000145	0.00226	CbGpPWpGaD
Pazopanib—FGFR1—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	0.000145	0.00226	CbGpPWpGaD
Pazopanib—PDGFRA—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	0.000145	0.00226	CbGpPWpGaD
Pazopanib—KIT—Signaling by EGFR—TSC2—vascular cancer	0.000145	0.00225	CbGpPWpGaD
Pazopanib—ITK—Adaptive Immune System—TSC2—vascular cancer	0.000144	0.00224	CbGpPWpGaD
Pazopanib—KIT—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.000143	0.00223	CbGpPWpGaD
Pazopanib—PDGFRB—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.000143	0.00223	CbGpPWpGaD
Pazopanib—KIT—Signaling by PDGF—TSC2—vascular cancer	0.000143	0.00222	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—WWTR1—vascular cancer	0.000141	0.0022	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by ERBB4—TSC2—vascular cancer	0.00014	0.00219	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism of lipids and lipoproteins—WWTR1—vascular cancer	0.00014	0.00219	CbGpPWpGaD
Pazopanib—FGFR1—DAP12 interactions—TSC2—vascular cancer	0.000138	0.00216	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by FGFR in disease—TSC2—vascular cancer	0.000138	0.00216	CbGpPWpGaD
Pazopanib—FGFR1—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.000138	0.00216	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by FGFR in disease—TSC2—vascular cancer	0.000138	0.00215	CbGpPWpGaD
Pazopanib—PDGFRA—DAP12 interactions—TSC2—vascular cancer	0.000138	0.00215	CbGpPWpGaD
Pazopanib—PDGFRA—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.000138	0.00215	CbGpPWpGaD
Pazopanib—FGFR2—B Cell Activation—TSC2—vascular cancer	0.000137	0.00214	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by EGFR—TSC2—vascular cancer	0.000137	0.00214	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by EGFR—TSC2—vascular cancer	0.000137	0.00213	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.000136	0.00212	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.000136	0.00211	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by PDGF—TSC2—vascular cancer	0.000135	0.00211	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by PDGF—TSC2—vascular cancer	0.000135	0.00211	CbGpPWpGaD
Pazopanib—KIT—B Cell Activation—TSC2—vascular cancer	0.000135	0.0021	CbGpPWpGaD
Pazopanib—PDGFRB—Downstream signal transduction—TSC2—vascular cancer	0.000134	0.00209	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by FGFR—TSC2—vascular cancer	0.000133	0.00208	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by ERBB2—TSC2—vascular cancer	0.000133	0.00207	CbGpPWpGaD
Pazopanib—PDGFRB—DAP12 signaling—TSC2—vascular cancer	0.000132	0.00206	CbGpPWpGaD
Pazopanib—FGFR2—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.000131	0.00205	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling by NGF—TSC2—vascular cancer	0.000131	0.00205	CbGpPWpGaD
Pazopanib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	0.00013	0.00203	CbGpPWpGaD
Pazopanib—KIT—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.000129	0.00201	CbGpPWpGaD
Pazopanib—FGF1—Disease—WWTR1—vascular cancer	0.000128	0.002	CbGpPWpGaD
Pazopanib—FGFR1—B Cell Activation—TSC2—vascular cancer	0.000128	0.002	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—CD34—vascular cancer	0.000128	0.002	CbGpPWpGaD
Pazopanib—PDGFRA—B Cell Activation—TSC2—vascular cancer	0.000128	0.00199	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—CD34—vascular cancer	0.000126	0.00196	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by FGFR in disease—TSC2—vascular cancer	0.000124	0.00194	CbGpPWpGaD
Pazopanib—PDGFRB—DAP12 interactions—TSC2—vascular cancer	0.000124	0.00194	CbGpPWpGaD
Pazopanib—PDGFRB—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.000124	0.00194	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by EGFR—TSC2—vascular cancer	0.000123	0.00192	CbGpPWpGaD
Pazopanib—FGFR1—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.000123	0.00191	CbGpPWpGaD
Pazopanib—PDGFRA—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.000122	0.00191	CbGpPWpGaD
Pazopanib—FGF1—Signaling by NGF—TSC2—vascular cancer	0.000122	0.00191	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.000122	0.00191	CbGpPWpGaD
Pazopanib—LYN—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.000122	0.0019	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by PDGF—TSC2—vascular cancer	0.000122	0.0019	CbGpPWpGaD
Pazopanib—LCK—Signaling by SCF-KIT—TSC2—vascular cancer	0.00012	0.00187	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—CD34—vascular cancer	0.000119	0.00186	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—CD34—vascular cancer	0.000119	0.00185	CbGpPWpGaD
Pazopanib—PDGFRB—B Cell Activation—TSC2—vascular cancer	0.000115	0.0018	CbGpPWpGaD
Pazopanib—LCK—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.000115	0.00179	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—CD34—vascular cancer	0.000113	0.00176	CbGpPWpGaD
Pazopanib—LCK—Signaling by ERBB4—TSC2—vascular cancer	0.000113	0.00176	CbGpPWpGaD
Pazopanib—LYN—B Cell Activation—TSC2—vascular cancer	0.000113	0.00176	CbGpPWpGaD
Pazopanib—PDGFRB—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.00011	0.00172	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—WWTR1—vascular cancer	0.000108	0.00168	CbGpPWpGaD
Pazopanib—LCK—Downstream signal transduction—TSC2—vascular cancer	0.000108	0.00168	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—CD34—vascular cancer	0.000107	0.00167	CbGpPWpGaD
Pazopanib—LCK—Signaling by FGFR—TSC2—vascular cancer	0.000107	0.00167	CbGpPWpGaD
Pazopanib—LCK—Signaling by ERBB2—TSC2—vascular cancer	0.000107	0.00166	CbGpPWpGaD
Pazopanib—LCK—DAP12 signaling—TSC2—vascular cancer	0.000106	0.00165	CbGpPWpGaD
Pazopanib—FGFR2—Disease—WWTR1—vascular cancer	0.000106	0.00165	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—CD34—vascular cancer	0.000105	0.00164	CbGpPWpGaD
Pazopanib—LCK—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	0.000105	0.00163	CbGpPWpGaD
Pazopanib—KIT—Disease—WWTR1—vascular cancer	0.000104	0.00162	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by NGF—TSC2—vascular cancer	0.000101	0.00158	CbGpPWpGaD
Pazopanib—LCK—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	9.98e-05	0.00156	CbGpPWpGaD
Pazopanib—LCK—Signaling by FGFR in disease—TSC2—vascular cancer	9.98e-05	0.00156	CbGpPWpGaD
Pazopanib—LCK—DAP12 interactions—TSC2—vascular cancer	9.98e-05	0.00156	CbGpPWpGaD
Pazopanib—KIT—Signaling by NGF—TSC2—vascular cancer	9.93e-05	0.00155	CbGpPWpGaD
Pazopanib—LCK—Signaling by EGFR—TSC2—vascular cancer	9.89e-05	0.00154	CbGpPWpGaD
Pazopanib—FGFR1—Disease—WWTR1—vascular cancer	9.88e-05	0.00154	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—WWTR1—vascular cancer	9.86e-05	0.00154	CbGpPWpGaD
Pazopanib—LCK—Signaling by EGFR in Cancer—TSC2—vascular cancer	9.8e-05	0.00153	CbGpPWpGaD
Pazopanib—LCK—Signaling by PDGF—TSC2—vascular cancer	9.76e-05	0.00152	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—WWTR1—vascular cancer	9.65e-05	0.00151	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by NGF—TSC2—vascular cancer	9.43e-05	0.00147	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—WWTR1—vascular cancer	9.4e-05	0.00147	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by NGF—TSC2—vascular cancer	9.4e-05	0.00147	CbGpPWpGaD
Pazopanib—FGF1—Immune System—CD34—vascular cancer	9.37e-05	0.00146	CbGpPWpGaD
Pazopanib—LCK—B Cell Activation—TSC2—vascular cancer	9.23e-05	0.00144	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—WWTR1—vascular cancer	8.97e-05	0.0014	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—WWTR1—vascular cancer	8.88e-05	0.00139	CbGpPWpGaD
Pazopanib—LCK—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	8.84e-05	0.00138	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—TSC2—vascular cancer	8.74e-05	0.00136	CbGpPWpGaD
Pazopanib—ITK—Immune System—TSC2—vascular cancer	8.71e-05	0.00136	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—CD34—vascular cancer	8.6e-05	0.00134	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by NGF—TSC2—vascular cancer	8.47e-05	0.00132	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—TSC2—vascular cancer	8.39e-05	0.00131	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—WWTR1—vascular cancer	8.06e-05	0.00126	CbGpPWpGaD
Pazopanib—FGFR3—Adaptive Immune System—TSC2—vascular cancer	8.05e-05	0.00126	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CD34—vascular cancer	7.76e-05	0.00121	CbGpPWpGaD
Pazopanib—KIT—Immune System—CD34—vascular cancer	7.62e-05	0.00119	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—WWTR1—vascular cancer	7.42e-05	0.00116	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—WWTR1—vascular cancer	7.29e-05	0.00114	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CD34—vascular cancer	7.23e-05	0.00113	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CD34—vascular cancer	7.21e-05	0.00112	CbGpPWpGaD
Pazopanib—LCK—Disease—WWTR1—vascular cancer	7.13e-05	0.00111	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—TSC2—vascular cancer	6.97e-05	0.00109	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—WWTR1—vascular cancer	6.92e-05	0.00108	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—WWTR1—vascular cancer	6.9e-05	0.00108	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—WWTR1—vascular cancer	6.81e-05	0.00106	CbGpPWpGaD
Pazopanib—LCK—Signaling by NGF—TSC2—vascular cancer	6.8e-05	0.00106	CbGpPWpGaD
Pazopanib—FGF1—Adaptive Immune System—TSC2—vascular cancer	6.69e-05	0.00104	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD34—vascular cancer	6.5e-05	0.00101	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD34—vascular cancer	6.36e-05	0.000992	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—WWTR1—vascular cancer	6.24e-05	0.000974	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—WWTR1—vascular cancer	6.22e-05	0.00097	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—WWTR1—vascular cancer	6.09e-05	0.00095	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—TSC2—vascular cancer	6.06e-05	0.000945	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—WWTR1—vascular cancer	5.78e-05	0.000902	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—TSC2—vascular cancer	5.77e-05	0.0009	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—TSC2—vascular cancer	5.67e-05	0.000884	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—WWTR1—vascular cancer	5.6e-05	0.000874	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—TSC2—vascular cancer	5.54e-05	0.000865	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—TSC2—vascular cancer	5.54e-05	0.000864	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—TSC2—vascular cancer	5.44e-05	0.000849	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—TSC2—vascular cancer	5.38e-05	0.000839	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—TSC2—vascular cancer	5.36e-05	0.000837	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD34—vascular cancer	5.21e-05	0.000813	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—TSC2—vascular cancer	5.16e-05	0.000805	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—TSC2—vascular cancer	5.15e-05	0.000803	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—WWTR1—vascular cancer	4.99e-05	0.000778	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—TSC2—vascular cancer	4.89e-05	0.000762	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—TSC2—vascular cancer	4.83e-05	0.000754	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—TSC2—vascular cancer	4.73e-05	0.000738	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—TSC2—vascular cancer	4.64e-05	0.000724	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—TSC2—vascular cancer	4.54e-05	0.000709	CbGpPWpGaD
Pazopanib—FGFR3—Disease—TSC2—vascular cancer	4.51e-05	0.000704	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—TSC2—vascular cancer	4.14e-05	0.000645	CbGpPWpGaD
Pazopanib—FGF1—Immune System—TSC2—vascular cancer	4.06e-05	0.000633	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—TSC2—vascular cancer	3.88e-05	0.000605	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—HBA1—vascular cancer	3.81e-05	0.000595	CbGpPWpGaD
Pazopanib—FGF1—Disease—TSC2—vascular cancer	3.75e-05	0.000585	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—TSC2—vascular cancer	3.72e-05	0.000581	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—WWTR1—vascular cancer	3.59e-05	0.00056	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—HBA1—vascular cancer	3.49e-05	0.000545	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—TSC2—vascular cancer	3.36e-05	0.000524	CbGpPWpGaD
Pazopanib—KIT—Immune System—TSC2—vascular cancer	3.3e-05	0.000515	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—HBA1—vascular cancer	3.24e-05	0.000505	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TSC2—vascular cancer	3.16e-05	0.000493	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—TSC2—vascular cancer	3.13e-05	0.000488	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—WWTR1—vascular cancer	3.13e-05	0.000488	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—TSC2—vascular cancer	3.12e-05	0.000487	CbGpPWpGaD
Pazopanib—FGFR2—Disease—TSC2—vascular cancer	3.1e-05	0.000484	CbGpPWpGaD
Pazopanib—KIT—Disease—TSC2—vascular cancer	3.05e-05	0.000475	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—WWTR1—vascular cancer	2.95e-05	0.00046	CbGpPWpGaD
Pazopanib—FGFR1—Disease—TSC2—vascular cancer	2.89e-05	0.000451	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—TSC2—vascular cancer	2.88e-05	0.00045	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TSC2—vascular cancer	2.82e-05	0.00044	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—TSC2—vascular cancer	2.81e-05	0.000439	CbGpPWpGaD
Pazopanib—LYN—Immune System—TSC2—vascular cancer	2.76e-05	0.00043	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TSC2—vascular cancer	2.75e-05	0.000429	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TSC2—vascular cancer	2.62e-05	0.000409	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—TSC2—vascular cancer	2.6e-05	0.000405	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—WWTR1—vascular cancer	2.5e-05	0.000389	CbGpPWpGaD
Pazopanib—LCK—Immune System—TSC2—vascular cancer	2.26e-05	0.000352	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TSC2—vascular cancer	2.17e-05	0.000339	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TSC2—vascular cancer	2.13e-05	0.000333	CbGpPWpGaD
Pazopanib—LCK—Disease—TSC2—vascular cancer	2.08e-05	0.000325	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TSC2—vascular cancer	2.02e-05	0.000316	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TSC2—vascular cancer	2.02e-05	0.000315	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—HBA1—vascular cancer	2.01e-05	0.000313	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—WWTR1—vascular cancer	1.93e-05	0.0003	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TSC2—vascular cancer	1.82e-05	0.000284	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TSC2—vascular cancer	1.78e-05	0.000278	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—HBA1—vascular cancer	1.75e-05	0.000273	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—HBA1—vascular cancer	1.65e-05	0.000257	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TSC2—vascular cancer	1.46e-05	0.000228	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—HBA1—vascular cancer	1.4e-05	0.000218	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—HBA1—vascular cancer	1.08e-05	0.000168	CbGpPWpGaD
